
Megrosi Plus 150mg/100mg Tablet
Marketer
Ridhima Biocare
Salt Composition
L-Ornithine L-Aspartate (150mg) + Pancreatin (100mg)
Overview Megrosi Plus 150mg/100mg Tablet
Digestive aid, Megrosi Plus 150mg/100mg tablets, treats indigestion by optimizing digestive processes. Administered with meals, dosage and treatment length are determined by your physician. Treatment duration aligns with your doctor's recommendations; premature cessation may lead to symptom recurrence and condition exacerbation. Disclose all medications to your healthcare provider, as interactions are possible. Common, typically transient, side effects include nausea, abdominal discomfort, flatulence, diarrhea, and constipation. Report any concerning side effects immediately. Constipation management involves increased fiber intake and hydration. Prior to commencing treatment, inform your doctor of any liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical advice. Optimal outcomes are enhanced by lifestyle adjustments: a high-fiber diet, increased fluid consumption, and regular physical activity.
Primary Ingredients of Megrosi Plus 150mg/100mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Megrosi Plus 150mg/100mg Tablet
Managing Digestive Upset
Major Benefits of Megrosi Plus 150mg/100mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Megrosi Plus 150mg/100mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with food.
Common Side effects of Megrosi Plus 150mg/100mg Tablet:
- Nausea
- Stomach pain
- Bloating
- Diarrhea
- Constipation
How to use Megrosi Plus 150mg/100mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Megrosi Plus 150mg/100mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Megrosi Plus 150mg/100mg Tablet works:
Combining L-Ornithine L-Aspartate (150mg/100mg) with pancreatin, Megrosi Plus tablets offer a three-pronged approach to liver health and digestive support. L-Ornithine lowers blood ammonia, assisting impaired liver function. Concurrently, L-Aspartate boosts cellular energy production and promotes liver cell repair. Pancreatin facilitates efficient nutrient absorption by improving digestion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Megrosi Plus 150mg/100mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Megrosi Plus 150mg/100mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Megrosi Plus 150mg/100mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Megrosi Plus 150mg/100mg Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Megrosi Plus 150mg/100mg Tablet use in individuals with renal impairment is scarce. Physician consultation is advised. Patients with pre-existing kidney conditions may experience elevated uric acid levels, necessitating careful monitoring.
LiverCONSULT YOUR DOCTOR
Data regarding Megrosi Plus 150mg/100mg Tablet use in individuals with hepatic impairment is scarce. Seek medical advice from your physician.
What if you forget to take Megrosi Plus 150mg/100mg Tablet :
Should you forget a dose of Megrosi Plus 150mg/100mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Megrosi Plus 150mg/100mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
